CORRECTION article

Front. Oncol.

Sec. Cancer Molecular Targets and Therapeutics

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1637363

This article is part of the Research TopicRenewed Insight into Cancer Mechanism and TherapyView all 31 articles

correction: FGFR3-TACC3 fusion gene promotes glioblastoma malignant progression through the activation of STAT3 signaling pathway

Provisionally accepted
Yiming LiYiming Li1Jianshen LiangJianshen Liang1,2,3Xiude RenXiude Ren1,2Jiahe GuoJiahe Guo1,2,3Xisen WangXisen Wang1,2,3Xuya WangXuya Wang1,2,3Sheng Ping YuSheng Ping Yu1,4Tao LiTao Li1,4Xuejun YangXuejun Yang1,2,3*
  • 1Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China
  • 2Laboratory of Neuro-oncology, Tianjin Medical University General Hospital, Tianjin, China
  • 3Department of Neurosurgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China
  • 4Laboratory of Neuro-Oncology, Tianjin Medical University General Hospital, Tianjin, China, Tianjin, China

This article is a correction to:

  1. FGFR3-TACC3 fusion gene promotes glioblastoma malignant progression through the activation of STAT3 signaling pathway

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

In the published article, there was an error in Figure 1F and Figure 3J as published. The error in the image presented in Figure 1F (U87MG F3-T3 K508R and U87MG Empty vector) and an incorrect use of scale bar in Figure 3J. The corrected Figure 1 and Figure 3 appear below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: FGFR3-TACC3 fusion gene, Glioma, malignant transformation, invasion, Migration, Stat3 signaling pathway

Received: 30 May 2025; Accepted: 04 Jun 2025.

Copyright: © 2025 Li, Liang, Ren, Guo, Wang, Wang, Yu, Li and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Xuejun Yang, Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material